期刊文献+

Graves病合并烟雾病的临床分析 被引量:1

Clinical analysis of patients with Graves disease and Moyamoya disease
下载PDF
导出
摘要 目的探讨Graves病(GD)合并烟雾病(MMD)的临床特征。方法对2例GD合并MMD患者的临床、实验室、影像学表现进行回顾性分析。结果 2例均为女性,GD先于MMD发病,随着甲亢症状被控制,神经系统症状有所改善。结论甲亢合并烟雾病仅见于女性,常于甲状腺毒血症期间发生脑卒中,控制甲亢有助于神经系统症状的恢复和防止复发。 Objective To explore the Clinical features of Graves disease (GD)combined with Moyamoya disease (MMD). Methods The manifestations of clinic,laboratory and neuroimaging in 2 patients with GD and MMD were retro-spectively analyzed. Results MMD combined with GD was more often seen in femal ( up to 100% in our study). Onset of GD was prior to MMD. With the function of thyroid improvement, the symptom of MMD can also be improved. Conclusion GD combined with MMD is only seen in females. Cerebral stroke commonly occurred during the presence of thyrotoxicosis. Anti - thyroid treatment is beneficial for recovery of the central nervous system and prevention of recurrence.
出处 《中国医学创新》 CAS 2009年第31期21-22,共2页 Medical Innovation of China
关键词 GRAVES病 烟雾病 分析 Graves disease Moyamoya disease Clinical analysis
  • 相关文献

参考文献5

  • 1莫家鹏,涂江龙,张明.Graves病合并烟雾病4例临床及病因分析[J].中风与神经疾病杂志,2007,24(4):478-480. 被引量:7
  • 2陈赞,菅凤增,王伊鹏,何川,凌锋.烟雾病免疫相关基因研究[J].中国脑血管病杂志,2005,2(5):198-201. 被引量:20
  • 3Y Mineharu,W Liu,K Inoue,N Matsuura,S Inoue,K Takenaka,H Ikeda,K Houkin,Y Takagi,K Kikuta,K Nozaki,N Hashimoto,A Koizumi.Autosomal dominant moyamoya disease maps to chromosome 17q25.3[J].Neurology ( Part of ).2008(24,Part2of2)
  • 4Ho Jun Seol,Kyu-Chang Wang,Seung-Ki Kim,Yong-Seung Hwang,Ki Joong Kim,Byung-Kyu Cho.Familial occurrence of moyamoya disease: a clinical study[J].Child’s Nervous System.2006(9)
  • 5Kaoru Sakurai,Yasue Horiuchi,Hidetoshi Ikeda,Kiyonobu Ikezaki,Takashi Yoshimoto,Masashi Fukui,Tadao Arinami.A novel susceptibility locus for moyamoya disease on chromosome 8q23[J].Journal of Human Genetics.2004(5)

二级参考文献21

  • 1[1]Wakai K, Tamakoshi A, Ikezaki K, et al. Epidemiogical features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg, 1997, 99(Suppl) 2: 1-5.
  • 2[2]Goto F, Yonekawa Y. World wide distribution of moyamoya disease. Neurol Med Chir, 1992, 32: 883-886.
  • 3[3]Kawano T, Fukui M, Hashimoto N, et al. Follow-up study of patients with "unilateral" moyamoya disease. Neurol Med Chir, 1994, 34: 744-747.
  • 4[4]Tanigawara T, Yamada H, Sakai N, et al. Studies on cytomegalovirus and Epstein-Bair virus infection in moyamoya disease. Clin Neurol Neurosurg, 1997, 99 (Suppl 2):225-228.
  • 5[5]Yashimoto T, Houkin K, Takahashi A, et al. A ngiogenic factors in moyamoya disease. Stroke, 1996, 27: 2160-2165.
  • 6[6]Inoue TK, Ikezaki K, Sasazuki T, et al. Analysis of class Ⅱ genes of human leukocyte antigen in patients with moyamoya diseases. Clin Neurol Neuro surg, 1997,99 (Suppl 2) :234-237.
  • 7[7]Moch H, Schraml P, Bubendorf L, et al. High throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinomal. Am J Pathol, 1999, 154: 981-986.
  • 8[8]Wang K, Can L, Jeffery E, et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene, 1999, 229: 101-108.
  • 9Liu JS,Luo SH,Chen WH,et al.A case of Graves' disease associated with intracranial Moyamoya vessels and tubular stenosis of extracranial internal carotid arteries[J].Formos Med Assoc,1994,93:806-809.
  • 10Tendler BE,Shoukri K,Malchoff C,et al.Concurrence of Graves' disease and dysplastic cerebral blood vessels of the Moyamoya variety[J].Thyroid,1997,7:625-629.

共引文献24

同被引文献3

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部